Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its ...
In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now locked in another big biotech deal.
Anthos Therapeutics, based in Cambridge, has a drug in late-stage clinical trials aimed at preventing strokes and blood clots.
On February 7, 2025, the Indian Space Research Organisation (ISRO) successfully conducted an ignition trial of the CE-20 ...
NASA's latest safety report raises concerns over the Artemis program, citing technical and budgetary risks, as well as health ...
GoogleFindMyTools is a re-implementation of Google's Find My Device network. It works with Android devices and ESP32-based ...
The Indian stock market continued its downward spiral for the fifth consecutive session, with the Sensex plunging 1,018 ...
ISRO confirms SpaDeX docking completed without issues Orbit raising stalled due to oxidiser valve malfunction Future experiments planned to enhance docking tech ...
India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...
Basel: Novartis today announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback